Velocimed
Latest round
- Series D
Last raised
- Sep 2004
Total raised
- $16M
Investors
- 4
About Velocimed
Based in Maple Grove, Minnesota, Velocimed is a private company focused on the development of three novel cardiovascular devices: (i) Proxis, the company’s lead product, designed to reduce the incidence of adverse outcomes due to the release of thrombotic emboli during high-risk coronary stenting procedures and representing the first proximal approach to coronary embolic protection; (ii) the Premere PFO Closure System, a patent foramen ovale (PFO) percutaneous closure device designed to seal a small channel in the septum of the heart between the atria, a common congenital defect associated with cryptogenic stroke; and (iii) the Venture Wire Control Catheter, a device designed to provide fine steering control and focused pushability to direct a standard guide wire through tight lesions.
Who invested in Velocimed
4 investors across 1 round
See all investors in Velocimed
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Sep 21, 2004
Amount
$16M
Investors
Questions about Velocimed
Who invested in Velocimed?
Velocimed has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Velocimed raised?
Velocimed has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Velocimed last raise money?
Velocimed's most recent round on record is a Series D, in Sep 2004.
What does Velocimed do?
Based in Maple Grove, Minnesota, Velocimed is a private company focused on the development of three novel cardiovascular devices: (i) Proxis, the company’s lead product, designed to reduce the incidence of adverse outcomes due to the release of thrombotic emboli during high-risk coronary stenting procedures and representing the first proximal approach to coronary embolic protection; (ii) the Premere PFO Closure System, a patent foramen ovale (PFO) percutaneous closure device designed to seal a small channel in the septum of the heart between the atria, a common congenital defect associated with cryptogenic stroke; and (iii) the Venture Wire Control Catheter, a device designed to provide fine steering control and focused pushability to direct a standard guide wire through tight lesions.
Where is Velocimed headquartered?
Velocimed is headquartered in Maple Grove, US.
Which VCs invest in companies like Velocimed?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Velocimed's stage. Their profiles are linked below.
VCs backing healthcare startups at Series D
Raising like Velocimed? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.